1. Companion Medical’s InPen Diabetes Management System Receives the US FDA’s Approval for Fixed Dosing and Meal Estimation Published: Feb 28, 2020 | Tags: Companion Medical, InPen Diabetes Management System, Receives, […]readmore
Tags : Paratek
Shots: Paratek to get exclusive rights to develop and commercialize sarecycline and will receive royalties on net sales of the product in the greater China region. Additionally, the companies are […]readmore
Shots: The P-III OASIS-2 study involves assessing of Nuzyra (qd, PO) vs Linezolid (PO, bid) in 735 patients with acute bacterial skin and skin structure infections (ABSSSI) The P-III OASIS […]readmore
Shots: The P-III OPTIC and OASIS-1 studies involves assessing of Nuzyra (Omadacycline) vs moxifloxacin & linezolid in 386 & 645 patients with community acquired bacterial pneumonia (CABP) & acute bacterial […]readmore